SEPARATION OF LIPOSOME-ASSOCIATED DOXORUBICIN FROM NON-LIPOSOME-ASSOCIATED DOXORUBICIN IN HUMAN-PLASMA - IMPLICATIONS FOR PHARMACOKINETIC STUDIES

被引：61

作者：

DRUCKMANN, S

GABIZON, A

BARENHOLZ, Y

机构：

[1] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT MEMBRANE BIOCHEM & NEUROCHEM,POB 1172,IL-91010 JERUSALEM,ISRAEL

[2] HADASSAH UNIV HOSP,DEPT ONCOL,JERUSALEM,ISRAEL

来源：

关键词：

D O I：

10.1016/0005-2736(89)90329-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：381 / 384

页数：4

共 18 条

[1] BEIJNEN J H, 1985, Journal of Parenteral Science and Technology, V39, P220
[2] EKSBORG S, 1982, CANCER CHEMOTH PHARM, V10, P7
[3] GABIZON A, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P43
[4] GABIZON A, 1982, CANCER RES, V42, P4734
[5] GABIZON A, 1989, IN PRESS LIPOSOMES T
[6] GREENE RF, 1983, CANCER RES, V43, P3417
[7] PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED ANTI-TUMOR DRUGS - STUDIES WITH VINBLASTINE, ACTINOMYCIN-D, CYTOSINE-ARABINOSIDE, AND DAUNOMYCIN
JULIANO, RL
STAMP, D
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) : 21 - 27
[8] REDUCTION OF DOXORUBICIN CARDIOTOXICITY BY PROLONGED CONTINUOUS INTRAVENOUS-INFUSION
LEGHA, SS
BENJAMIN, RS
MACKAY, B
EWER, M
WALLACE, S
VALDIVIESO, M
RASMUSSEN, SL
BLUMENSCHEIN, GR
FREIREICH, EJ
[J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) : 133 - 139
[9] LIPOSOMAL AMPHOTERICIN-B FOR THE TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH CANCER - A PRELIMINARY-STUDY
LOPEZBERESTEIN, G
FAINSTEIN, V
HOPFER, R
MEHTA, K
SULLIVAN, MP
KEATING, M
ROSENBLUM, MG
MEHTA, R
LUNA, M
HERSH, EM
REUBEN, J
JULIANO, RL
BODEY, GP
[J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) : 704 - 710
[10] LOWRY OH, 1951, J BIOL CHEM, V193, P265